2019 Company of the Year - BioAlberta
September 25, 2019 - Metabolomic Technologies Inc. was presented with the BioAlberta Company of the Year Award at the 20th Annual BioAlberta Awards Gala. This Award was presented to MTI for excellence and innovation with their flagship product, PolypDx™, and their strong performance and leadership role in the Alberta business community. MTI was presented the award by Bob Dawson, Senior Manager, Patient Access and Health Policy, from Pfizer Canada.
2017 Finalist - Falling Walls Venture - Berlin, Germany
Metabolomic Technologies Inc. was selected as one of 22 outstanding science based start-ups from leading international academic institutions and international venture capitalists in the Falling Walls Venture competition held in Berlin, Germany. As a finalist for the competition, Dr. Chang presented MTI's easy-to-use test for the screening and prevention of colorectal cancer to a gathering of science based start-ups, investors and opinion leaders at the British Embassy in Berlin.
2017 ASTech Foundation Outstanding Leadership in Technology Award
Metabolomic Technologies Inc. is the 2017 recipient of the Outstanding Leadership in Technology Award from the ASTech Foundation. The ASTech Foundation award recognizes outstanding innovation in science and technology. MTI was selected for the development of an innovative and easy-to-use diagnostic test for the detection and prevention and colorectal cancer - PolypDx™.
2017 ATB Catalyst Export Award
Metabolomic Technologies Inc. was the 2017 recipient of the ATB Catalyst Export Award. The award recognizes MTI's engagement in international business and export contribution that have made an impact to both the provincial and national economy, while achieving excellence through sustainable growth and innovation.
2014 North American Frost & Sullivan Award for Technology Innovation Leadership
Metabolomic Technologies Inc. was awarded the Award for Technology Innovation Leadership by Frost & Sullivan. Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications.
2013 Spin-Off Achievement Award
Metabolomic Technologies Inc. was presented with the Spin-off Achievement Award at the 2013 "Innovation... Makes Sense" event, celebrating the commercialization of University of Alberta technologies. Metabolomic Technologies received this award in recognition of their success as a spin-off from the university.
TEC Edmonton Enterprise Award
Granted to MTI at the 2012 TEC Connector event, the TEC Edmonton Enterprise Award recognizes outstanding achievement by an early-stage technology-based company. MTI was selected for their achievements in entrepreneurship, growth and contributions to the health, business and innovation communities.